193 related articles for article (PubMed ID: 7689236)
1. Clinical diagnosis and staging of prostatic carcinoma.
Alcini E; D'Addessi A
Rays; 1993; 18(1):3-13. PubMed ID: 7689236
[No Abstract] [Full Text] [Related]
2. Markedly raised serum prostate specific antigen levels. Prostatic infarction rather than malignancy?
Kiran PR
Aust Fam Physician; 2001 May; 30(5):458-60. PubMed ID: 11432019
[TBL] [Abstract][Full Text] [Related]
3. [Detection of prostate cancer: yes or no?].
Van Cangh PJ
Bull Mem Acad R Med Belg; 2006; 161(3-4):159-69. PubMed ID: 17172224
[No Abstract] [Full Text] [Related]
4. Prostate carcinoma: clarification through clinical insight and molecular diagnostics.
Meyers FJ; DeVere White RW
West J Med; 1998 Jun; 168(6):525. PubMed ID: 9655997
[No Abstract] [Full Text] [Related]
5. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
[TBL] [Abstract][Full Text] [Related]
6. Acid phosphatase, alkaline phosphatase and prostate specific antigen: which markers should we choose?
Cooper EH; Siddall JK; Newling DW; Robinson MR
Prog Clin Biol Res; 1988; 269():43-56. PubMed ID: 2455911
[No Abstract] [Full Text] [Related]
7. Clinical examination, radiology and markers in the follow-up of prostatic carcinoma.
De Santis M
Rays; 1993; 18(1):115-26. PubMed ID: 8356236
[No Abstract] [Full Text] [Related]
8. [Use of prostate specific antigen. A review].
Brasso K; Skaarup P; Roosen JU; Iverson P
Ugeskr Laeger; 1998 Jul; 160(31):4510-6. PubMed ID: 9700305
[TBL] [Abstract][Full Text] [Related]
9. [Various immunohistochemical markers of precancer and variants of prostate cancer].
Romanenko AM; Vorob'eva LR
Arkh Patol; 1995; 57(4):38-41. PubMed ID: 8526754
[TBL] [Abstract][Full Text] [Related]
10. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
[No Abstract] [Full Text] [Related]
11. [Study of alpha1-antichymotrypsin (ACT) in prostatic carcinoma].
Karseladze AI; Rytin IE; Matveev VB
Arkh Patol; 2005; 67(1):30-3. PubMed ID: 15822791
[TBL] [Abstract][Full Text] [Related]
12. [Cancer of the prostate. Diagnosis, prognosis, principles of treatment].
Lopez JG; Perrin P
Rev Prat; 1999 Feb; 49(3):297-301. PubMed ID: 10189800
[No Abstract] [Full Text] [Related]
13. Medical technologies for the diagnosis of prostate cancer.
Fitzsimons NJ; Sun L; Moul JW
Expert Rev Med Devices; 2007 Mar; 4(2):227-39. PubMed ID: 17359227
[TBL] [Abstract][Full Text] [Related]
14. [Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level].
Wetter A; Ajdukovic AN; Fliessbach K; Lehnert T; Engl T; Jacobi V; Vogl TJ
Rofo; 2006 Apr; 178(4):385-90. PubMed ID: 16607587
[TBL] [Abstract][Full Text] [Related]
15. [A case of prostatic adenocarcinoma with pulmonary metastases--diagnosis by transbronchial lung biopsy and immunohistochemistry].
Nishi K; Amemiya T; Ooka T; Kurumaya H; Fujimaru M; Matsuda T
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Oct; 32(10):1001-5. PubMed ID: 7531254
[TBL] [Abstract][Full Text] [Related]
16. Critical-laboratoristic correlation of the diagnostic importance of prostate specific antigen compared with prostatic acid phosphatase and carcinoembryonic antigen in the prostatic cancer.
Milani M; Tacconi R; Marsili G; Trognoni A; Centioni G; Leoni T; Fumarola A
Quad Sclavo Diagn; 1986 Dec; 22(4):428-32. PubMed ID: 2445000
[No Abstract] [Full Text] [Related]
17. Non-systematic screening for prostate cancer in Sweden--survey from the National Prostate Cancer Registry.
Stattin P; Johansson R; Damber JE; Hellström M; Hugosson J; Lundgren R; Varenhorst E; Johansson JE
Scand J Urol Nephrol; 2003; 37(6):461-5. PubMed ID: 14675917
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy.
Merrick GS; Gutman S; Andreini H; Taubenslag W; Lindert DL; Curtis R; Adamovich E; Anderson R; Allen Z; Butler W; Wallner K
Eur Urol; 2007 Sep; 52(3):715-23. PubMed ID: 17337114
[TBL] [Abstract][Full Text] [Related]
19. [Clinical profiles of prostate cancer in our hospital: association between primary symptoms and clinical stage].
Kimura T; Ikemoto I; Ohishi Y
Hinyokika Kiyo; 2000 Feb; 46(2):83-6. PubMed ID: 10769794
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of serum markers for prostate cancer.
Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]